Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: A pilot study

Journal of Vascular and Interventional Radiology

Volumn 13, Issue 1, 2002, Pages 37-43

  Drescher, Peter ^a   Crain, Martin R ^a   Rilling, William S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Abciximab; Arteries, peripheral; Arteries, stenosis or obstruction; Peripheral vascular disease; Reteplase; Thrombolysis

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; RETEPLASE;

ADULT; AGED; AMPUTATION; ANGIOGRAPHY; ARTERY CATHETER; ARTERY GRAFT; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOT LYSIS; BYPASS SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; DOPPLER FLOWMETRY; DRUG EFFICACY; DRUG INFUSION; FEMALE; FIBRINOLYTIC THERAPY; GRAFT PATENCY; HEMATOMA; HEPARINIZATION; HUMAN; LIMB ISCHEMIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036147816     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(07)60006-2     Document Type: Article

References (32)

1. Surgical management of severe acute lower extremity ischemia
2. Basic data related to clinical decision making in acute limb ischaemia
3. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia
4. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity
5. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs
6. Mechanisms of thrombus formation and lysis
7. Blockade of platelet glycoprotein IIb/IIIa receptors as an antithrombotic strategy
8. A comparison of reteplase with alteplase for acute myocardial infarction
9. Abciximab improved both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction: Observations from the TIMI 14 trial
10. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction: Strategies for patency enhancement in the emergency department (SPEED) group
11. Thrombolysis in the management of lower limb peripheral arterial occlusion a consensus document
12. SCVIR reporting standard for the treatment of acute limb ischemia with the use of transluminal removal of arterial thrombus
13. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease
14. Acute peripheral arterial occlusion: Predictors of success in catheter-directed thrombolytic therapy
15. The case of Abbokinase and the FDA: The events leading to the suspension of Abbokinase supplies in the United States
16. Alteplase: A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction
17. Thrombolytic agents in development
18. Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator BM 06.622 in healthy volunteers
19. Effect of reteplase on hemostasis variables: Analysis of fibrin specificity, relation to bleeding complications and coronary patency
20. Initial results of reteplase in the treatment of acute lower extremity arterial occlusions
21. Reteplase in the treatment of peripheral arterial and venous occlusions: A pilot study
22. Acetylsalicylic acid, platelets and thrombosis: Theory and practice
23. GP IIb/IIIa antagonists: Pathophysiologic and therapeutic insights from studies of c7E3 fab
24. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators: Observations in animals and humans
25. Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO III trial)
26. Short and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral arterial occlusive disease and arterial thrombolysis
27. Platelet glycoprotein II/IIIa receptor antagonist used in conjunction with thrombolysis for peripheral arterial thrombosis
28. A simplified procedure for intraarterial thrombolysis with t-PA in peripheral arterial occlusive disease: Primary and long-term results
29. Thrombolytic therapy with use of alteplase (t-PA) in peripheral arterial occlusive disease: Review of the clinical literature
30. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter directed arterial and venous thrombolysis
31. Vascular surgical society of Great Britain and Ireland: Avoiding the complications of thrombolysis
32. Tissue plasminogen activator in peripheral arterial thrombolysis